Bibliographic Details
| Title: |
[Regulatory Practices and Implications of FDA Approving New Drug Indication under the Medical Device Pathway]. |
| Authors: |
Jiang J; Shenyang Pharmaceutical University, Shenyang, 110016.; Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd., Shanghai, 201210.; Shanghai Engineering Research Center of Photodynamic Drugs, Shanghai, 201210., Shao Y; Shenyang Pharmaceutical University, Shenyang, 110016. |
| Source: |
Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation [Zhongguo Yi Liao Qi Xie Za Zhi] 2025 Nov 30; Vol. 49 (6), pp. 681-688. |
| Publication Type: |
English Abstract; Journal Article |
| Journal Info: |
Publisher: Guo jia yi yao guan li ju Yi liao qi xie qing bao zhong xin zhan Country of Publication: China NLM ID: 9426153 Publication Model: Print Cited Medium: Print ISSN: 1671-7104 (Print) Linking ISSN: 16717104 NLM ISO Abbreviation: Zhongguo Yi Liao Qi Xie Za Zhi Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
